203 related articles for article (PubMed ID: 19571253)
1. An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.
Dorgham K; Ghadiri A; Hermand P; Rodero M; Poupel L; Iga M; Hartley O; Gorochov G; Combadière C; Deterre P
J Leukoc Biol; 2009 Oct; 86(4):903-11. PubMed ID: 19571253
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
[TBL] [Abstract][Full Text] [Related]
3. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
4. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
[TBL] [Abstract][Full Text] [Related]
5. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells.
Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP
Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
[TBL] [Abstract][Full Text] [Related]
7. E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1
Wakita H; Yanagawa T; Kuboi Y; Imai T
Mol Pharmacol; 2017 Nov; 92(5):502-509. PubMed ID: 28842393
[TBL] [Abstract][Full Text] [Related]
8. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
9. Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.
Fevang B; Yndestad A; Damås JK; Bjerkeli V; Ueland T; Holm AM; Beiske K; Aukrust P; Frøland SS
Clin Immunol; 2009 Feb; 130(2):151-61. PubMed ID: 18938112
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
[TBL] [Abstract][Full Text] [Related]
11. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.
Oh DJ; Dursun B; He Z; Lu L; Hoke TS; Ljubanovic D; Faubel S; Edelstein CL
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F264-71. PubMed ID: 18003857
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2',3'-dideoxyguanosine.
Depboylu C; Eiden LE; Schäfer MK; Reinhart TA; Mitsuya H; Schall TJ; Weihe E
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1170-80. PubMed ID: 17146291
[TBL] [Abstract][Full Text] [Related]
14. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
Marchesi F; Piemonti L; Fedele G; Destro A; Roncalli M; Albarello L; Doglioni C; Anselmo A; Doni A; Bianchi P; Laghi L; Malesci A; Cervo L; Malosio M; Reni M; Zerbi A; Di Carlo V; Mantovani A; Allavena P
Cancer Res; 2008 Nov; 68(21):9060-9. PubMed ID: 18974152
[TBL] [Abstract][Full Text] [Related]
15. Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue.
El-Shazly AE; Doloriert HC; Bisig B; Lefebvre PP; Delvenne P; Jacobs N
Clin Exp Allergy; 2013 Mar; 43(3):322-31. PubMed ID: 23414540
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CX
Becker F; Holthoff C; Anthoni C; Rijcken E; Alexander JS; Gavins FN; Spiegel HU; Senninger N; Vowinkel T
Int J Colorectal Dis; 2017 Mar; 32(3):315-324. PubMed ID: 27942903
[TBL] [Abstract][Full Text] [Related]
17. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
Gupta S; Erdmann G; Schulz-Maronde S; Escher SE; Richter R; Forssmann WG; Elsner J; Forssmann U
Allergy; 2008 Oct; 63(10):1317-23. PubMed ID: 18782110
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.
D'Haese JG; Demir IE; Friess H; Ceyhan GO
Expert Opin Ther Targets; 2010 Feb; 14(2):207-19. PubMed ID: 20055718
[TBL] [Abstract][Full Text] [Related]
19. The CX3CL1-CX3CR1 system and psoriasis.
Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
[TBL] [Abstract][Full Text] [Related]
20. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
